Induction of Apoptosis of CD4+ T Cells by Immunomodulatory Therapy of Multiple Sclerosis with Glatiramer Acetate

Publisher： Karger

E-ISSN： 1421-9913|50|4|200-206

ISSN： 0014-3022

Source： European Neurology, Vol.50, Iss.4, 2003-11, pp. : 200-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and Glatiramer Acetate

By  

European Neurology, Vol. 65, Iss. 4, 2011-03 ,pp. : 231-232

Karger

Access to resources Recommend Favorite

Patterns of Th1/Th2 Cytokines Predict Clinical Response in Multiple Sclerosis Patients Treated with Glatiramer Acetate

By  

European Neurology, Vol. 65, Iss. 3, 2011-03 ,pp. : 164-169

Karger

Access to resources Recommend Favorite

Anaphylactic Reaction after Injection of Glatiramer Acetate (Copaxone®) in Patients with Relapsing-Remitting Multiple Sclerosis

By  

European Neurology, Vol. 66, Iss. 6, 2011-11 ,pp. : 368-370

Karger

Access to resources Recommend Favorite

Fatigue Improvement after Switching Multiple Sclerosis Treatment from Interferon-β to Glatiramer Acetate in Clinical Practice

By  

European Neurology, Vol. 76, Iss. 1-2, 2016-07 ,pp. : 40-47

Karger

Access to resources Recommend Favorite

HIV1-associated CD4 T lymphocyte apoptosis

By Lelievre J.-D.   Arnoult D.   Petit F.   Estaquier J.  

La Revue de Medecine Interne, Vol. 24, Iss. 8, 2003-08 ,pp. : 522-529

Elsevier

Access to resources Recommend Favorite